“Integra is a leader in the hand and wrist arthroplasty market,” said Bob Davis, corporate vice president and president, Orthopedics and Tissue Technologies. “Adding a wrist plating system to our portfolio elevates Integra into a one-stop solution for our customers’ wrist needs- from fracture plating to fusion and arthroplasty.”
The LOQTEQ distal radius system features state-of-the-art designs with multiple plate options to accommodate a variety of fracture patterns and anatomies, as well as instrumentation designed for intra-operative efficiency.
“We are looking forward to expanding our footprint in the US with a proven force in the upper extremity field. The alliance between aap and Integra is a natural fit for both companies and will additionally drive our dynamic development in North America,” said Bruke Seyoum Alemu, CEO of aap.
Integra’s industry-leading products in the upper extremity market include the Freedom Wrist Arthroplasty System and the PyroCarbon MCP prosthesis.
Based in Plainsboro, N.J., Integra LifeSciences offers innovative solutions, including leading plastic and regenerative technologies, in specialty surgical solutions, and orthopedics and tissue technologies.
aap’s aspiration is to make trauma treatment better and cost-effective through innovations dedicated to create a sustainable value for patients, surgeons and hospitals. The company provides a plates and screws portfolio for mainstream trauma and has a pipeline with new products. aap’s IP-protected core platform technologies are the LOQTEQ locking compression technology, its antimicrobial silver coating technology and its resorbable coated magnesium implants technology.